Clearside Biomedical names industry veteran, Thomas Crawford, as VP of supply chain


Clearside Biomedical (NASDAQ:CLSD) appointed Thomas Crawford, a certified supply chain professional, as VP of supply chain.

Mr. Crawford will be responsible for establishing and managing Clearside’s global supply chain for clinical testing, training and, if approved, trade distribution of suprachoroidal CLS-TA, the company’s proprietary suspension of the corticosteroid, triamcinolone acetonide, formulated for administration to the back of the eye via the suprachoroidal space.

In a career spanning more than 25 years, Mr. Crawford has extensive expertise in supply chain management, trade relations, product launches, and manufacturing operations.

Before joining Clearside, he was VP of supply chain and customer service for Pharma Tech Industries, the world’s largest pharmaceutical contract manufacturer and packager of powder products. His earlier experience includes supply chain, manufacturing and trade relations management roles at various pharmaceutical and medical device companies, including Shionogi, Immucor, Aronex Pharmaceuticals, Allergan, Abbot Labs and Zenith Goldline Pharmaceuticals.

“Thomas will be in a position to provide seamless distribution management for suprachoroidal CLS-TA to many of our global testing sites and, if suprachoroidal CLS-TA is approved, in support of our commercial supply,” president and CEO, Daniel White, said in a statement.

Sydney Stewart